Category: St. Jude MedicalSyndicate content

Cardiovascular leaders to huddle on Riata recall

January 13, 2012 by MassDevice staff

Physicians from the Minneapolis Heart Institute Foundation and Mayo Clinic organize a one-day summit in the Twin Cities to focus on the recall of St. Jude Medical's Riata leads.

Riata Lead Summit

Physicians from the Minneapolis Heart Institute Foundation and the Mayo Clinic will huddle with electro-physiologists in the Twin Cities Jan. 20 to discuss strategies for dealing with the recall of the Riata defibrillator leads made by St. Jude Medical Inc. (NYSE:STJ).

The FDA slapped the St. Paul, Minn.-based cardiology device maker with a Class 1 recall for the Riata leads in December, after the company said they failed more frequently than previously reported.

MassDevice.com +3 | BSX aims for double-digit EPS growth, St. Jude's Libra helps Parkinson's patients, Judge grants ex-Stryker Biotech exec's request to sever charges in fraud case

January 11, 2012 by MassDevice staff

The top three medical device stories for January 11, 2012.

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com's coverage highlights our three biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

St. Jude's Libra helps patients with Parkinson's

January 11, 2012 by MassDevice staff

Deep brain stimulation systems from St. Jude Medical helps manage symptoms of Parkinson's disease, study says.

A deep brain stimulation implant made by St. Jude Medical's (NYSE:STJ) proved effective in the treatment of patients Parkinson's disease, according to results published in The Lancet.

The 136-patient study compared patients suffering from Parkinson's who were implanted with St. Jude's Libra and LibraXP DBS systems with and without stimulation. The study enrolled patients who had suffered from Parkinson's for at least 5 years, or who had 6 hours a day with diminished motor symptom control and muscle ticks.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

JP Morgan 2012: A slew of med-tech companies preview earnings

January 10, 2012 by MassDevice staff

Volcano, CareFusion, St. Jude Medical and a clutch of other medical device firms tip their cap on the upcoming earnings season at the JP Morgan Conference.

JP Morganl

A slew of medical device companies are providing a sneak preview of the upcoming earnings season at the JP Morgan Conference in San Francisco this week.

MassDevice is on site at the conference and will have updates coming throughout the week on one of the largest meetings of the medical technology investment community.

Wall Street breathes "sigh of relief" on St. Jude Medical's prelim earnings report

January 9, 2012 by MassDevice staff

St. Jude Medical officials say the company likely to meet its guidance for fourth quarter in preliminary earnings announcement: CRM business drops 4 percent

St. Jude Medical

Shares of St. Jude Medical (NYSE:STJ) jumped nearly 5% in early trading on Wall Street as the St. Paul, Minn.-based cardiac device maker said it was likely to meet its previously stated earnings guidance for the fourth quarter of 2011.

MassDevice.com +7 | Synthes goes after Stryker, Oridion shares drop after import ban, FDA aims at reused med-tech, Accuray and Siemens amend ties, SNN spins out biologics unit, FDA releases December recalls and St. Jude expands in Plymouth

January 7, 2012 by MassDevice staff

The top seven medical device stories for the week of January 2, 2012.

Plus Seven

Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else this weekend, make sure you're still in the know with MassDevice +7.

Bankers' outlook grim for U.S. IPOs | Wall Street Beat

January 5, 2012 by MassDevice staff

Bankers' confidence in U.S. initial public offering growth for 2012 takes a heavy hit, as China tops the international list for largest IPO market in 2011.

Wall Street Beat

Bankers aren't expecting much excitement in the U.S. market for initial public offerings this year, as China spends another year at the top.

About half of the 100 capital markets execs surveyed predict growth in IPOs this year, compared to 72% of those surveyed in advance of 2011, according to BDO USA, an accounting and consulting firm.

Only 16% of those surveyed expected any growth to be "significant," while 35% expect flat growth and 15% predicted that the market will continue to slide.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp